Kaempferol reduces matrix metalloproteinase-2 expression by down-regulating ERK1/2 and the activator protein-1 signaling pathways in oral cancer cells.
<h4>Background</h4>Kaempferol has been proposed as a potential drug for cancer chemoprevention and treatment because it is a natural polyphenol contained in plant-based foods. Recent studies have demonstrated that kaempferol protects against cardiovascular disease and cancer. Based on th...
Guardado en:
Autores principales: | Chiao-Wen Lin, Pei-Ni Chen, Mu-Kuan Chen, Wei-En Yang, Chih-Hsin Tang, Shun-Fa Yang, Yih-Shou Hsieh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8aca4accfdbc4fd999b1a55305befa3d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Interleukin-1β-induced matrix metalloproteinase-3 via ERK1/2 pathway to promote mesenchymal stem cell migration.
por: Chun-Hao Chang, et al.
Publicado: (2021) -
DACH1 inhibits breast cancer cell invasion and metastasis by down-regulating the transcription of matrix metalloproteinase 9
por: Sattout Aman, et al.
Publicado: (2021) -
Matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2, and transforming growth factor beta 1 in the aqueous humor and serum of patients with pseudoexfoliation syndrome
por: Kara S, et al.
Publicado: (2014) -
Inhibition of ERK 1/2 kinases prevents tendon matrix breakdown
por: Ulrich Blache, et al.
Publicado: (2021) -
miRNA-29c suppresses lung cancer cell adhesion to extracellular matrix and metastasis by targeting integrin β1 and matrix metalloproteinase2 (MMP2).
por: Heyong Wang, et al.
Publicado: (2013)